Transactions
13
Insider / NUCOR CORP
West Nadja
Director at NUCOR CORP
- Company
- NUCOR CORP
- First filing on record
- December 17, 2025
- Latest trade on record
- September 2, 2026
- SEC filings
- EDGAR ↗
West Nadja, Director at NUCOR CORP, has disclosed 13 transactions in THC, TEM, NUE and 1 more since December 17, 2025: 0 purchases (0 open-market buys) and 6 sales, worth about $1.7M at the reported prices. The latest was filed September 3, 2026, 1 day after the trade; 1 filing was late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
6
Avg. disclosure lag
2.8d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months West Nadja made no purchases and 6 sales worth $1.7M, plus 7 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
West Nadja has traded 2 stocks on record; the largest by dollars is THC.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 10 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| S | Open-market sale | 5 | 12,330 | $1.6M |
| A | Grant or award | 4 | 8,831 | — |
| M | Option exercise or conversion | 2 | 2,666 | — |
| D | Sale back to the company | 1 | 493 | $86K |
| G | Gift | 1 | 1,515 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 12 | 0 | 5 · $1.3M |
| 2025 | 1 | 0 | 1 · $430K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| THC | Sell S | September 2, 2026 | September 3, 2026 | 1d | 1,152 | $259 | $298K | Form 4 ↗ | ||
| TEM | Sell S | August 28, 2026 | September 1, 2026 | 4d | 3,000 | $69 | $207K | 10b5-1 plan | Form 4 ↗ | |
| TEM | Sell S | August 14, 2026 | August 18, 2026 | 4d | 3,000 | $54 | $162K | 10b5-1 plan | Form 4 ↗ | |
| NUE | Other A | June 1, 2026 | June 3, 2026 | 2d | 755 | — | — | Form 4 ↗ | ||
| THC | Other A | May 27, 2026 | May 28, 2026 | 1d | 1,188 | — | — | derivative | Form 4 ↗ | |
| THC | Sell S | May 27, 2026 | May 28, 2026 | 1d | 3,000 | $177 | $532K | Form 4 ↗ | ||
| TEM | Other A | May 21, 2026 | May 26, 2026 | 5d | 5,913 | — | — | late | Form 4 ↗ | |
| THC | Option / conversion M | May 22, 2026 | May 26, 2026 | 4d | 1,333 | — | — | derivative | Form 4 ↗ | |
| THC | Sell D | May 22, 2026 | May 26, 2026 | 4d | 493 | $174 | $86K | Form 4 ↗ | ||
| THC | Option / conversion M | May 22, 2026 | May 26, 2026 | 4d | 1,333 | — | — | Form 4 ↗ | ||
| JNJ | Other A | April 23, 2026 | April 27, 2026 | 4d | 975 | — | — | derivative | Form 4 ↗ | |
| THC | Other G | February 17, 2026 | February 18, 2026 | 1d | 1,515 | — | — | Form 4 ↗ | ||
| THC | Sell S | December 15, 2025 | December 17, 2025 | 2d | 2,178 | $197 | $430K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| September 3, 2026 | Form 4 | 0001193125-26-382368 | 1 | published | EDGAR ↗ |
| September 1, 2026 | Form 4 | 0001787802-26-000006 | 1 | published | EDGAR ↗ |
| August 18, 2026 | Form 4 | 0001787802-26-000004 | 1 | published | EDGAR ↗ |
| June 3, 2026 | Form 4 | 0000073309-26-000119 | 1 | published | EDGAR ↗ |
| May 28, 2026 | Form 4 | 0001193125-26-245811 | 2 | published | EDGAR ↗ |
| May 26, 2026 | Form 4 | 0001193125-26-239941 | 3 | published | EDGAR ↗ |
| May 26, 2026 | Form 4 | 0001787802-26-000002 | 1 | published | EDGAR ↗ |
| April 27, 2026 | Form 4 | 0000200406-26-000111 | 1 | published | EDGAR ↗ |
| February 18, 2026 | Form 4 | 0001193125-26-057752 | 1 | published | EDGAR ↗ |
| December 17, 2025 | Form 4 | 0001193125-25-323306 | 1 | published | EDGAR ↗ |
Other insiders at NUCOR CORP
- LEFKOFSKY ERIC P CEO and Chairman 144 rows
- Fukushima Ryan Chief Operating Officer 40 rows
- Wolk Joseph J Exec VP, CFO 34 rows
- Schmid Timothy EVP, WW Chair, MedTech 31 rows
- Topalian Leon J Director 29 rows
- Broadhurst Vanessa EVP, Global Corp Affairs 25 rows
- Swanson James D. EVP, CIO 24 rows
- Wengel Kathryn E EVP, Chief TO and Risk Officer 24 rows
- Duato Joaquin CEO and Chairman of the Board 23 rows
- Taubert Jennifer L Director 23 rows
Everyone on file, with contracts and lobbying under the company's name: NUCOR CORP.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 10 | 13 | December 17, 2025 | September 3, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.